Whitepapers

 

From IBD to IMIDs
Why a Cross-Disease Perspective Is Essential for More Informed and Holistic Care

This whitepaper explores how fragmented care limits our understanding of inflammatory bowel disease (IBD), particularly when it coexists with other immune‑mediated inflammatory diseases (IMIDs). 

It shows how siloed  clinical and research practices overlook the full patient journey, and how Real‑World Evidence can enable more holistic, integrated care.

Screenshot 2026-06-10 at 16.02.56

 

From Trials to Practice: Reducing the knowledge Gap in Treatment Pathways with Real-World Data

This whitepaper is about how real-world evidence helps reduce uncertainty in treatment pathways. It explains how observational data, healthcare observatories, and collaborative frameworks offer insights into long-term outcomes and rare side effects, supporting better decisions and improving patient care.

Screenshot 2026-04-30 at 15.28.06

RTIs Today: What We Know, What We Miss, and How Real-World Evidence Can help

RTIs are more common, and more complex, than current data suggests. Discover the hidden gaps in diagnosis, surveillance and treatment, and how Real‑World Evidence can finally bring clarity to RTI care.
 
Screenshot 2026-03-05 at 08.55.48

Get clarity and control to make better decisions.

Do you have any questions about harnessing data-driven insights for better financial analytics or seek advice?  Allow our experts, such as Sarah, to lead the way.

They will reply within 48 hours on business days.

Speak to an expertRequest a demo
_DSF3228-1